Aemetis Inc

Aemetis Inc (AMTX) Stock Analysis

$1.445

+0.015 (+1.05%)At close

Loading chart…
High
1.470
Open
1.400
VWAP
1.43
Volume
639.60K
Mkt Cap
134.08M
Low
1.380
Amount
915.70K
EV/EBITDA, TTM
11.92

Aemetis, Inc. is a renewable natural gas and renewable fuels company. The Company focused on the operation, acquisition, development and commercialization of technologies that lower fuel costs and reduce emissions. The Company’s segments include California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The California Ethanol segment consists of an approximately 65 million gallons per year ethanol plant in Keyes, California. The California Dairy Renewable Natural Gas segment is engaged in the production and sale of renewable natural gas and associated environmental attributes, consisting of anaerobic digesters located at diaries, a 36-mile biogas collection pipeline, and a biogas upgrading hub and pipeline interconnect that produces Renewable Natural Gas from the biogas. The India Biodiesel segment includes a biodiesel production plant in Kakinada, India with a production capacity of over 80 million gallons per year and administrative offices in Hyderabad, India.

AI analysis of Aemetis Inc (AMTX)

Sell

Aemetis Inc is not a good buy right now due to its current price of 1.66, a very low RSI of 27.31 indicating oversold conditions, and a significant net loss of 21.56% gross margin in the latest quarter.

Analyst Ratings (1)

+1284.08% upside
Hold
0 Buy
1 Hold
0 Sell
Current: 1.45
Low
20.00
Average
20.00
High
20.00

Ascendiant

2025-06-06

Price Target

$20

Buy

UBS

2025-05-09

Price Target

—

Buy

Ascendiant Capital

2025-03-17

Price Target

$19

Strong Buy

HC Wainwright & Co.

2025-03-14

Price Target

$28

Strong Buy

HC Wainwright & Co.

2024-12-23

Price Target

$28

Strong Buy

Valuation Metrics

The current forward P/E ratio for Aemetis Inc (AMTX) is 58.82, compared to its 5-year average forward P/E of 4.12.

Forward P/E

Strongly Overvalued
5Y Average P/E
4.12
Current P/E
58.82
Overvalued
25.54
Undervalued
-17.31

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
66.65
Current EV/EBITDA
11.92
Overvalued
353.55
Undervalued
-220.24

Forward P/S

Fair
5Y Average P/S
0.61
Current P/S
0.30
Overvalued
1.12
Undervalued
0.09

Alphio AI Price Scenarios for AMTX

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%AMTX

$1.94

Scenario price

B

Base

Base · 50%AMTX

$1.60

Scenario price

B

Bear

Bear · 25%AMTX

$1.00

Scenario price

Events Timeline

2026-08-06 (ET)

09:30:00

Aemetis Q2 Revenue at $62.7M, Below Expectations

2026-05-07 (ET)

09:20:00

Aemetis Reports Q1 Revenue of $54.62M

2026-03-12 (ET)

08:10:00

Aemetis Q4 Revenue $43.307M, Below Consensus

2026-02-03 (ET)

08:30:00

Aemetis Subsidiary Secures $24M Biodiesel Orders

2025-12-30 (ET)

08:10:00

Aemetis Secures $17M in Federal Clean Energy Tax Credits

News

AMTX FAQ — answered by Alphio AI

Aemetis, Inc. is a renewable natural gas and renewable fuels company. The Company focused on the operation, acquisition, development and commercialization of technologies that lower fuel costs and reduce emissions. The Company’s segments include California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The California Ethanol segment consists of an approximately 65 million gallons per year ethanol plant in Keyes, California. The California Dairy Renewable Natural Gas segment is engaged in the production and sale of renewable natural gas and associated environmental attributes, consisting of anaerobic digesters located at diaries, a 36-mile biogas collection pipeline, and a biogas upgrading hub and pipeline interconnect that produces Renewable Natural Gas from the biogas. The India Biodiesel segment includes a biodiesel production plant in Kakinada, India with a production capacity of over 80 million gallons per year and administrative offices in Hyderabad, India. It operates in the Energy sector (INDUSTRIAL ORGANIC CHEMICALS industry).

Aemetis Inc is not a good buy right now due to its current price of 1.66, a very low RSI of 27.31 indicating oversold conditions, and a significant net loss of 21.56% gross margin in the latest quarter.

1 analysts cover AMTX: 0 rate it Buy, 1 Hold and 0 Sell. The average price target is 20.00.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading